Trifluridine-Tipiracil plus Regorafenib vs Trifluridine-Tipiracil plus Bevacizumab for Refractory Metastatic Colorectal Cancer: A Randomized, Controlled, Open-Label, Non-Inferiority, Phase III trial

Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2025
This article has no abstract
Epistemonikos ID: 74ad0adefdb04285c19d5c66eb43ae0a29b16554
First added on: Apr 22, 2026